Pharmaceutical Industry in
Delémont

Zoetis Schweiz GmbH

Since 2012 · 21–50 empl.

The core activity of Zoetis is the research, development, production and marketing of medicines, vaccines, diagnostics and technologies for animal health, particularly for livestock and companion animals.

Protaccine Biotec Sàrl

Since 2017 · 11–20 empl.

The core activity of Protaccine Biotec Sarl is the development and production of high-quality anti-snake venom sera, other antiserum-based products, thermostable vaccines and biological products based on new technologies at affordable prices. Additionally, the company offers consulting services and turnkey solutions for the vaccine and biotechnology industry, and supports patients in various treatments, including cancer treatments through immunotherapy and gene therapy.

Caland SA

Since 2019 · 1–10 empl.

Caland SA develops cannabis-based formulations with an emphasis on scientific rigor, precise dosing, transparency and carefully selected ingredients. The company also states that it follows a responsible approach based on sustainable partnerships and environmental and social responsibility.

Genetas AG

Since 2007 · 1–10 empl.

Genetas AG operates a personal blog on its website featuring posts about science, research, and everyday topics. The content is presented as editorial writing rather than as a description of business services.

BIO-UR SA

Since 2008 · 1–10 empl.